m+Medelevator.RU
← Поиск публикаций
Journal of hepato-biliary-pancreatic sciences · 2025

Propensity Score-Matched Comparison of Robotic and Laparoscopic Pancreaticoduodenectomy.

СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Shyr Bor-Shiuan, Wang Shin-E, Chen Shih-Chin, Shyr Yi-Ming, Shyr Bor-Uei

Аннотация

BACKGROUND: Robotic pancreaticoduodenectomy (RPD) has theoretical advantages over laparoscopic pancreaticoduodenectomy (LPD), offering enhanced dexterity with EndoWrist technology and improved ergonomics. This study aimed to compare surgical outcomes between RPD and LPD.

METHODS: Patients undergoing minimally invasive pancreaticoduodenectomy, including 679 RPD and 94 LPD, were included for comparison before and after propensity score matching (PSM).

RESULTS: After 1:1 PSM, 88 cases were analyzed in each group. The RPD group showed significantly shorter operation times (median: 7.5 vs. 11.0 h, p < 0.001). Complications were lower in the RPD group (46.6% vs. 65.9%, p = 0.010 overall; 9.1% vs. 19.3%, p = 0.010 for major complications with Clavien-Dindo ≥ III). Postoperative pancreatic fistula (POPF) was lower in the RPD group (3.4% vs. 12.5%, p = 0.026 for overall; 5.1% vs. 16.9%, p = 0.040 for soft parenchyma of pancreas; 4.1% vs. 16.7%, p = 0.042 for non-dilated pancreatic ducts). In the LPD group, all vascular resections required open conversion, whereas 42.9% of vascular resections were performed robotically in the RPD group (p = 0.013). There was no significant difference between RPD and LPD regarding intraoperative blood loss, conversion, vascular resection, surgical mortality, or survival outcomes.

CONCLUSIONS: RPD offers several advantages over LPD, including shorter operation time, lower morbidity, and reduced incidence of major complications and POPF, especially in patients with soft pancreas and non-dilated pancreatic ducts.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты